US Patent Issued to Regeneron Pharmaceuticals, Sanofi Biotechnology on Dec. 23 for "Methods for treating atopic dermatitis by administering an IL-4R antagonist" (American, French Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,429, issued on Dec. 23, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.) and Sanofi Biotechnology (Paris).

"Methods for treating atopic dermatitis by administering an IL-4R antagonist" was invented by Marius Ardeleanu (White Plains, N.Y.), Neil Graham (Croton-on-Hudson, N.Y.), Jennifer Davidson Hamilton (Ridgefield, Conn.), Stephane C. Kirkesseli (Paris), Sudeep Kundu (New York), Jeffrey Ming (Bridgewater, N.J.), Allen Radin (New York), Ross E. Rocklin (Basking Ridge, N.J.) and Steven Paul Weinstein (Hartsdale, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating atopic dermatitis (A...